Company intelligence / Profile preview

Lansdowne Partners

London, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Lansdowne Partners is a leading London-based investment management firm established in 1998; it is known for equity investing and hedge fund strategies but has no roles or programs in health, life sciences, biotech, or pharma. It is an active, private company, not public, and is not acquired. Its closest connection with the life science area is as a potential investor or asset manager, not as a drug developer, manufacturer, or healthcare provider.

Industry: Investors

Partnerships

Morgan Stanley Investment Management

Beyond the preview

Go deeper on Lansdowne Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lansdowne Partners.

Explore the full profile